Can medications used for trigeminal neuralgia cause psychosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Medications for Trigeminal Neuralgia Cause Psychosis?

Yes, certain medications used for trigeminal neuralgia can cause psychosis, most notably levetiracetam and carbamazepine, though the risk varies significantly by agent.

Primary Offenders

Levetiracetam poses the highest risk among commonly used anticonvulsants for trigeminal neuralgia. In a study of patients with epilepsy who developed psychotic disorders, 84.6% of those with antiepileptic drug-induced psychosis were taking levetiracetam, compared to only 20.2% in the non-drug-induced psychosis group 1. The psychosis typically manifests with disorganized behaviors and thinking (100% of cases), and importantly, has a better prognosis than other forms of psychosis—patients rarely require continuous antipsychotic treatment (only 15.4%) and none experienced a chronic course 1.

Carbamazepine, the first-line medication for trigeminal neuralgia, can also precipitate psychosis, though interestingly it showed a negative association with drug-induced psychosis in the multivariate analysis 1. However, a critical caveat exists: abrupt withdrawal of carbamazepine after toxic levels can trigger acute psychosis several days after discontinuation 2. This withdrawal-induced psychosis is particularly relevant in trigeminal neuralgia patients who may develop toxicity and require medication adjustment.

Risk Factors to Monitor

Female patients with temporal lobe involvement face significantly higher risk of developing antiepileptic drug-induced psychosis 1. When prescribing medications for trigeminal neuralgia, particularly in women, maintain heightened vigilance for psychiatric symptoms.

Clinical Implications for Medication Selection

The standard treatment hierarchy for trigeminal neuralgia includes:

  • First-line: Carbamazepine and oxcarbazepine (sodium channel blockers) 3, 4
  • Second-line: Gabapentinoids (gabapentin, pregabalin) 5, 3
  • Refractory cases: Lacosamide, eslicarbazepine, botulinum toxin 4

Notably, gabapentinoids (pregabalin, gabapentin) are not associated with psychosis risk in the available evidence, making them safer alternatives when psychiatric concerns exist 5. While they commonly cause somnolence, dizziness, and mental clouding—especially problematic in older adults—these side effects differ fundamentally from frank psychosis 5.

Practical Management Approach

When initiating anticonvulsants for trigeminal neuralgia:

  • Avoid levetiracetam as a first choice if psychiatric history or risk factors exist
  • If using carbamazepine and toxicity develops, taper slowly rather than abrupt discontinuation to prevent withdrawal psychosis 2
  • Consider gabapentinoids as safer alternatives when psychosis risk is a concern
  • Monitor female patients and those with temporal lobe pathology more closely for psychiatric symptoms 1

Prognosis When Psychosis Occurs

The good news: antiepileptic drug-induced psychosis in this context typically resolves with medication adjustment and has substantially better outcomes than primary psychotic disorders 1. Most patients do not require long-term antipsychotic treatment, and chronic courses are rare.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.